Video Classification as IR Task: Experiments and Observations

Jens Kürsten,Maximilian Eibl

DOI: https://doi.org/10.1007/978-3-642-15751-6_49

2009-09-30

Abstract:

What problem does this paper attempt to address?

Retinoblastoma treatment in a Brazilian population. Presentation and long‐term results

Maria Teresa Brizzi Chizzotti Bonanomi,Maria Tereza A. de Almeida,Marianna A. Hollaender,Roberta Chizzotti Bonanomi,Mario Luiz Ribeiro Monteiro

DOI: https://doi.org/10.1002/cam4.6683

IF: 4.711

2024-01-21

Cancer Medicine

Abstract:We report the clinical features and outcomes of patients with retinoblastoma treated with systemic chemotherapy and local consolidation with a follow‐up period of greater than 2 years in Brazil. We discuss the high‐risk features of this neoplasm and emphasize the high success rate obtained, including 92% survival and reading visual acuity in 72.8% of bilateral disease. Introduction Retinoblastoma is a malignant tumor with a high cure potential when proper therapy is used. The purpose of this paper is to report the clinical features and outcomes of patients with retinoblastoma who were treated with a combination of local and systemic chemotherapy‐based protocols. Method We retrospectively studied patients treated with systemic chemotherapy plus local treatment between 2003 and 2015 with a follow‐up ≥2 years. We correlated clinical and pathological characteristics with decimal visual acuity (VA) and death. Results Among 119 patients, 60% had unilateral disease (UNI), and 52% were male. The median presentation age was 19.5 months, 10% had a positive family history, and the most frequent sign was leukocoria (68.8%). Advanced disease was more frequent in eyes with UNI (98.4%) than in eyes with bilateral retinoblastoma (BIL: 55.3%). Enucleation was performed in 97% of UNI eyes and in 55.8% of BIL eyes. The overall globe salvage was 26.6%, 44.25% of BIL eyes. Bilateral enucleation was required in 5%. High‐risk pathologic features occurred in 50% and 37% of eyes enucleated without and with neoadjuvant chemotherapy, respectively. High‐risk features were related to the presence of goniosynechiae in the pathologic specimen and were more frequent in children younger than 10 months or older than 40 months. Extraocular disease was present in 5% of patients, and the death rate related to metastasis of the tumor was 8%. The final VA was ≥ 0.7 in 72.8% and ≥0.1 in 91% of BIL patients. Conclusions Treatment of retinoblastoma with conservative systemic‐based chemotherapy was associated with an excellent survival rate (92%). Albeit the low overall globe salvage rate, in BIL patients, approximately half the eyes were conserved, and a satisfactory functional visual result was achieved The evaluated protocol is an important treatment option, especially in developing countries.

oncology
Strategies to improve diagnosis and access to treatment of retinoblastoma in low‐ and middle‐income countries: A systematic review

Bruna Salgado Rabelo,Kevin Augusto Farias de Alvarenga,Luiz Fernando Lopes,Adeylson Guimarães Ribeiro,Karla Emilia de Sá Rodrigues

DOI: https://doi.org/10.1002/pbc.30987

2024-04-11

Pediatric Blood & Cancer

Abstract:Retinoblastoma, the most common intraocular tumor in childhood, still faces challenges in diagnosis and treatment, particularly in low‐ and middle‐income countries. Identifying strategies to improve the time to diagnosis and access to treatment is crucial to enhance survival rates and preserve ocular health. We conducted a systematic review to identify interventions that have demonstrated potential in addressing these challenges. We performed a comprehensive search across databases until March 2023. Out of the studies reviewed, 21 met the inclusion criteria and were categorized into five main areas: surveillance strategies, genetic counseling, education, public assistance, and international partnership. Despite the obstacles faced, the initiatives identified in this review present acts toward improving the time to diagnosis and access to treatment for retinoblastoma. Based on the extracted data, we propose a comprehensive chain of initiatives. We firmly believe that implementing this chain of initiatives can lead to improved clinical outcomes for retinoblastoma patients.

oncology,pediatrics,hematology
Philippine retinoblastoma initiative multi-eye center study 2010-2020

Roland Joseph D. Tan,,Patricia E. Cabrera,Paulita Pamela P. Astudillo,Rolando Enrique D. Domingo,Josept Mari S. Poblete,Charmaine Grace M. Cabebe,Adriel Vincent R. Te,Melissa Anne S. Gonzales,Jocelyn G. Sy,Beltran Alexis A. Aclan,Jayson T. So,Fatima G. Regala,Kimberley Amanda K. Comia,Josemaria M. Castro,Mara Augustine S. Galang,Aldous Dominic C. Cabanlas,Benedicto Juan E. Aguilar,Gabrielle S. Evangelista,Jo Michael Maniwan,Andrei P. Martin,Calvin Y. Martinez,John Alfred H. Lim,Rena Ivy Bascuna,Rachel M. Ng,Kevin B. Agsaoay,Kris Zanna A. Acluba-Arao,Ellaine Rose V. Apostol,Beatriz M. Prieto,,,,,,,,,,,,,,,,,,,,,,,,,,,

DOI: https://doi.org/10.18240/ijo.2024.01.20

IF: 1.645

2024-01-18

International Journal of Ophthalmology

Abstract:AIM: To provide a comprehensive and more representative national data on the disease, especially on treatment options and outcomes, and to determine access of retinoblastoma patients from Luzon, Visayas and Mindanao to eye care, and determine if access is associated with delay in consultation, staging and outcomes. METHODS: Cohort study of retinoblastoma patients seen in eleven institutions located in the three major areas of the Philippines namely Luzon, Vizayas and Mindanao from 2010-2020. RESULTS: Totally 636 patients, involving 821 eyes, were included. Majority (57%) were from Luzon and were seen in institutions in Luzon (72%). Annually, 58±10 new cases were seen with 71% having unilateral disease. Median delay of consultation remained long at 9 (3, 17)mo, longest in patients with unilateral disease (P&#x003C;0.02) and those from the Visayas (P&#x003C;0.003). Based on the International Retinoblastoma Staging System, only 35% of patients had Stage 1 while 47% already had extraocular disease. Enucleation was the most common treatment received by 484 patients while intravenous chemotherapy was received by 469. There were 250 (39%) patients alive, 195 (31%) dead, 85 (13%) abandoned, 17 (3%) refused and 89 (14%) with no data. CONCLUSION: This study presents the largest cohort of retinoblastoma patients in the Philippines in terms of patients' and participating institutions' number and geographical location and type of institution (private and public). It also presents more comprehensive data on the treatments used and outcomes (survival, globe salvage, and vision retention rates). Delay in consultation was still long among patients leading to advanced disease stage and lower survival rate. Despite increasing capacity to diagnose and manage retinoblastoma in the country, the delay of consultation remains long primarily due to accessibility issues to eye care institutions especially in the Visayas and financial concerns. The delay was still significant that overall survival rate remain low.

ophthalmology
Role of apparent diffusion map in the evaluation of retinoblastoma

Viviane Souto Spadoni,Thaylla Maybe Bedinot da Conceição,Flávia da Costa Schaefer,Daniel Schmidt Ercolani,Marcelo Krieger Maestri,Amalia Klaes,Simone Geiger Selistre,Fabiano Reis,Juliana Ávila Duarte

DOI: https://doi.org/10.5935/0004-2749.2021-0435

2024-01-01

Arquivos Brasileiros de Oftalmologia

Abstract:PURPOSE: This study aimed to analyze the association between magnetic resonance imaging apparent diffusion coefficient map value and histopathological differentiation in patients who underwent eye enucleation due to retinoblastomas.METHODS: An observational chart review study of patients with retinoblastoma that had histopathology of the lesion and orbit magnetic resonance imaging with apparent diffusion coefficient analysis at Hospital de Clínicas de Porto Alegre between November 2013 and November 2016 was performed. The histopathology was reviewed after enucleation. To analyze the difference in apparent diffusion coefficient values between the two major histopathological prognostic groups, Student's t-test was used for the two groups. All statistical analyses were performed using SPSS version 19.0 for Microsoft Windows (SPSS, Inc., Chicago, IL, USA). Our institutional review board approved this retrospective study without obtaining informed consent.RESULTS: Thirteen children were evaluated, and only eight underwent eye enucleation and were included in the analysis. The others were treated with photocoagulation, embolization, radiotherapy, and chemotherapy and were excluded due to the lack of histopathological results. When compared with histopathology, magnetic resonance imaging demonstrated 100% accuracy in retinoblastoma diagnosis. Optic nerve invasion detection on magnetic resonance imaging showed a 66.6% sensitivity and 80.0% specificity. Positive and negative predictive values were 66.6% and 80.0%, respectively, with an accuracy of 75%. In addition, the mean apparent diffusion coefficient of the eight eyes was 0.615 × 103 mm2/s. The mean apparent diffusion coefficient value of poorly or undifferentiated retinoblastoma and differentiated tumors were 0.520 × 103 mm2/s and 0.774 × 103 mm2/s, respectively.CONCLUSION: This study revealed that magnetic resonance imaging is useful in the diagnosis of retinoblastoma and detection of optic nerve infiltration, with a sensitivity of 66.6% and specificity of 80%. Our results also showed lower apparent diffusion coefficient values in poorly differentiated retinoblastomas with a mean of 0.520 × 103 mm2/s, whereas in well and moderately differentiated, the mean was 0.774 × 103 mm2/s.

ophthalmology
EPID-07. EPIDEMIOLOGICAL CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH DIFFUSE GLIOMA IN BRAZIL: PRELIMINARY RESULTS OF A MULTICENTRIC RETROSPECTIVE STUDY - LACOG 0619

Camilla Yamada,Carolina Vasques,Rodrigo Coutinho,Marcos Maldaun,Clarissa Baldotto,Fabiana Viola,Fernando Maluf,Vanessa Santos,Carolina Pessoa,Patrícia Pacheco,Danielli Matias,Daniela Oliveira,Fernanda Peria,Rafaela de Jesus,Taiane Rebelatto,Suzana Malheiros

DOI: https://doi.org/10.1093/neuonc/noab196.340

2021-11-02

Abstract:Abstract INTRODUCTION In Brazil, most of the 9,196 deaths due to brain cancers in 2017 were gliomas. There is a dearth of epidemiological data on diffuse glioma in Brazil. METHODS LACOG 0619 is a multicentric retrospective cohort study, which included patients from nine tertiary oncology centers. Patients aged ≥18 years with histologically proven astrocytoma, oligodendroglioma, oligoastrocytoma or glioblastoma diagnosed from June 2010 to June 2019 were included. The study protocol was approved by each Institutional Review Board. RESULTS 642 patients were included in the analysis. Median age was 51.0 (19-91) years. Most patients were male (n=364, 56.8%), 175 (27.3%) had ECOG 0-1, and 480 (74.8%) had private healthcare insurance. Neurological symptoms were present in 568 (88.5%) patients at diagnosis, and 263 (41.0%) had a history of seizure before surgery. Regarding histology, 361 (56.2%) had glioblastoma, 162 (25.2%) had astrocytoma, 90 (14.0%) had oligodendroglioma, and 23 (3.6%) had glioma NOS. Gross total resection was performed in 168 (26.2%), subtotal resection in 292 (45.5%), biopsy in 108 (16.8%), conventional radiotherapy in 380 (59.2%), and hypofractionation in 44 (6.9%) patients. Concomitant chemoradiotherapy was administered to 370 (57.6%) patients, mostly with temozolamide (n=362, 97.8%). Furthermore, 434 (67.7%) patients received maintenance chemotherapy, 398 with temozolamide (< 6 cycles in 112 [28.4%], 6 cycles in 75 [18.8%], and >6 cycles in 214 [3.8%]). Median follow-up was 29 months (26-33). Median OS according to histology was: 35 months (95%CI 26-46) for glioblastoma, 91 months (95%CI 35-NR) for glioma NOS, and not reached for astrocytoma and oligodendroglioma. Median OS by number of temozolamide maintenance cycles was 18 months (95%CI 15-24) for < 6 cycles and not reached for 6 cycles or more. CONCLUSIONS This is the first multicentric cohort evaluating Brazilian patients with diffuse glioma, providing important data on epidemiology, treatment patterns, and survival in the country.

oncology,clinical neurology
Improved SOVA-based decoding algorithm for tailbiting codes on wireless channels

Jorge Ortín,P. García,F. Gutiérrez,A. Valdovinos

DOI: https://doi.org/10.1109/ISWPC.2010.5483722

2010-05-05

Abstract:Tailbiting convolutional codes will be used for several applications in new cellular mobile radio systems. This encoding method does not reset the encoder memory at the end of each data block, avoiding the overhead of the zero tail and improving the efficiency, especially when encoding short data blocks. Nevertheless, the absence of a known tail highly increases the complexity of the decoding process. This fact added to the high computational burden of maximum likelihood (ML) decoding have made necessary the development of decoding algorithms which achieve good performance in terms of computational complexity and error correction capabilities. In this work we propose a novel decoding algorithm for tailbiting codes which is suitable for wireless environments with steep variations in channel conditions. The proposed method performs two different Viterbi decodings of the received data. In the first one, the most likely state is estimated with a modified version of the soft-output Viterbi algorithm (SOVA). If the path with the best metric decoded in the first step is not tailbiting, a second Viterbi decoding is performed. In this case, the state estimated in the previous step is employed as the initial and final states of the trellis. Simulations results obtained in an orthogonal frequency division multiplexing (OFDM) system over a wireless channel are close to the performance of the maximum-likelihood decoding and other proposed algorithms.
Clinical Characteristics and Treatment Outcome of Children with Intraocular Retinoblastoma: A Report from A Chinese Cooperative Group

Yi-Jin Gao,Jiang Qian,Han Yue,Yi-Fei Yuan,Kang Xue,Yi-Qun Yao

DOI: https://doi.org/10.1002/pbc.23002

2011-01-01

Pediatric Blood & Cancer

Abstract:Background. To present the characteristics and treatment outcome of patients with intraocular retinoblastoma in a Chinese cooperative group. Procedure. Between January 2005 and March 2009, 159 eyes of 133 patients with retinoblastoma were included in this retrospective study. The International Classification of Retinoblastoma (ICRB) staging system was noted for each patient. Cases with visible extraocular extension at diagnosis were excluded. The patient data were reviewed for demographic information, clinical findings, and managements. Results. Of 133 cases, there were 83 (62%) male and 50 (38%) female, ranging in age from 2 months to 134 months (median, 23 months; mean, 26 months). There were 26 bilateral cases (20%). One hundred and twenty-four cases (93%) were deemed sporadic and nine cases (7%) were deemed familial. Leukocoria was the most common presenting symptom. One hundred and twenty-three eyes (77%) of 123 patients (92%) had no visual potential. Only 36 eyes (23%) of 30 patients (23%) utilized vision-preserving treatments. The ocular salvage rate was 83% (30/36) for this group. The cumulative probability of survival was 98% (Kaplan-Meier method) at 60 months follow up. Conclusions. The overall survival rate of this study is in agreement with data from developed countries. In appropriate patients, systemic chemotherapy, and focal ophthalmic therapy are effective and carry little morbidity. Compared with more medically developed countries, there are still many challenges in the management of retinoblastoma in China. Early detection and doctor education should be an important future goal. Pediatr Blood Cancer 2011;57:1113-1116. (C) 2011 Wiley Periodicals, Inc.
A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt

Hossam Elzomor,Hala Taha,Radwa Nour,Adel Aleieldin,M Saad Zaghloul,Ibrahim Qaddoumi,Ahmad S Alfaar

DOI: https://doi.org/10.1080/13816810.2016.1227995

Abstract:Background: Retinoblastoma poses a substantial burden in developing countries. We conducted this study to assess the effect of implementing a multidisciplinary approach and standardized protocols for treating pediatric patients with retinoblastoma at the Children's Cancer Hospital Egypt (CCHE). Materials and methods: In January 2011, the CCHE implemented standardized protocols for the diagnosis, treatment, and reporting of retinoblastoma cases. The hospital also introduced a new retinoblastoma management algorithm and data analysis system. In this study, we compared the pathologic features, tumor invasiveness, reporting, and survival of 276 pediatric patients who underwent enucleations of 290 eyes before or after the implementation of the retinoblastoma protocols. Results: Time to enucleation (indicating time needed for decision taking) decreased significantly within the neoadjuvant chemotherapy group for intraocular disease after January 2011 (68.7 ± 48 weeks vs. 47.3 ± 28.3 weeks; p < 0.05). Mean optic nerve stump length increased from 5.6 mm in the earlier period to 7.2 mm in the later period (p = 0.004). The overall quality of pathology reporting also improved during the later period. The probability of 3-year survival was significantly higher for patients during the later period (94.2% vs. 79.2%; p = 0.018). Conclusions: The implementation of standardized protocols and a multidisciplinary approach improved reporting; discrepancies in disease classification and the amount of missing data were reduced; and quality measures and prognostic capabilities of the team were substantially improved. Such established data-driven practice supports faster decision making to enucleate diseased eyes and save patients' lives through providing measurable indicators.
Myocardial contrast and transesophageal echocardiographic study of the left coronary artery from the main pulmonary artery.

J. Vargás-Barrón,N. Espinola-Zavaleta,Á. Romero‐Cárdenas,L. Crespo Serje,R. Villavicencio-Fernández,C. Keirns,G. Eid Lidt

1998-05-01

Abstract:A case of a 26-year-old woman with thoracic pain and anomalous origin of the left coronary artery from the main pulmonary artery is described. The diagnosis was by coronary angiography and complemented with Doppler and transesophageal myocardial contrast.
Treatment outcomes in retinoblastoma and the effect of tumor topography

Wajiha J. Kheir,Andre Slim,Dalia El Hadi,Elie Bechara,Raphah Borghol,Dolly Noun,Christiane Al‐Haddad

DOI: https://doi.org/10.1002/pbc.31334

2024-09-19

Pediatric Blood & Cancer

Abstract:Background Retinoblastoma, the most common intraocular malignancy in children, has high fatality rates if untreated. It is crucial to monitor treatment effectiveness and explore factors influencing favorable outcomes. Our study aims to examine how tumor location impacts the response to standard treatments and the achievement of favorable outcomes among retinoblastoma patients, while controlling for other tumor‐related factors. Methods This retrospective study analyzed medical records of retinoblastoma patients from November 2012 to December 2022 enrolled in the retinoblastoma program at the Children's Cancer Center of Lebanon (established in collaboration with St.y Jude Children's Research Hospital, Memphis, TN). Data were extracted from the electronic chart reviews and operative reports of examinations under anesthesia (EUAs), and included patient's demographics, tumor characteristics (size, location), and treatment parameters (treatment type, resolution, recurrence). Results The study included 42 patients with retinoblastoma, with a total of 57 eyes and 115 tumors/lesions. The median age at diagnosis was 12 months (range: 2–36 months). Among the patients, 26 (61.9%) were males and 16 (38.1%) were females. A minority of patients (21.4%) presented with unilateral involvement, whereas the majority (78.6%) had bilateral involvement. The locations of retinoblastoma lesions were distributed as follows: optic nerve (4.4%), macula (19.1%), superior (16.5%), inferior (17.4%), nasal (27.8%), and temporal (14.8%). Resolution rate tended to be highest for tumors close to optic nerve and temporal lesions, but no statistical significance was attained (p = .45). Macular lesions tended to have the fastest resolution, but again not significantly (p = .5). Multiple logistic regression revealed that the odds for resolution of tumor was not significantly associated with tumor size (p = .57) or location (p = .52). Conclusion Location of retinoblastoma lesions was not directly associated with recurrence‐free resolution in our cohort. Further research in large retinoblastoma databases is needed to explore the association of tumor characteristics with recurrence and the need for secondary therapeutic interventions.

oncology,pediatrics,hematology
Urinary interleukin-8/creatinine level as a predictor of response to intravesical bacillus Calmette-Guerin therapy in bladder tumor patients.

R. Rabinowitz,Deborah S. Smith,D. Tiemann,M. Hudson

DOI: https://doi.org/10.1016/S0022-5347(01)64111-9

1997-11-01

Abstract:
Characteristics and prognosis of young breast cancer patients treated in a public comprehensive cancer centre in Brazil: A retrospective cohort study

Karina Belickas Carreiro,Rodrigo Goncalves,Bruna Salani Mota,José Maria Soares Jr,Edmund Chada Baracat,José Roberto Filassi

DOI: https://doi.org/10.1016/j.canep.2023.102437

Abstract:Background: The incidence of breast cancer among women under 41 years old varies worldwide, with higher rates observed in developing countries. These young women often face later-stage diagnoses. In this study, we examine a cohort of young women who were treated for breast cancer in São Paulo, Brazil. Methods: We conducted a retrospective cohort study involving women under 41 years old. Our objective was to describe patient and treatment characteristics, with the main outcomes being overall and disease-free survival. Our analysis explored the associations between age of menarche, history of breastfeeding, use of hormonal contraceptives, and age at diagnosis. Results: Our study included 493 patients with a mean follow-up of 62.8 months. The mean age of the patients was 34.6 (SD=4.19). Of the patients, 68% presented with locally advanced disease, and 19.27% were metastatic at the time of diagnosis. We observed significant associations between age of menarche and age at diagnosis (p = 0.0096), as well as age at diagnosis and breastfeeding (p = 0.0232). Chemotherapy was administered to 92.91% of the patients as part of their treatment, while 27.2% were eligible for breast-conserving surgery. During the follow-up period, 153 patients died, with disease progression being the cause of death in 73.2% of cases. The median survival time for the entire cohort is still under review, while the metastatic patients at diagnosis had a median survival time of 28.64 months (95%CI 20.21-40.89). Conclusion: Our findings highlight significant associations between late-stage diagnosis and overall and disease-free survival in this patient age group. Given that the majority of patients present with locally advanced breast cancer, it is crucial to implement strategies that promote early-stage diagnosis and improve survival rates.
Ruptured 'Baker's-type cyst' of the arm--a case study.

E. Roddy,V. Lim,K. Fairbairn,I. Pande

DOI: https://doi.org/10.1093/RHEUMATOLOGY/KEG164

2003-05-01

Rheumatology

Abstract:
Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system

Thabata Martins Ferreira Campuzano,Maria Amelia Carlos Souto Maior Borba,Paula de Mendonça Batista,Michelle Nadalin,Cicera Pimenta Marcelino,Paula Cristina Pungartnik,Angélica Carreira dos Santos,Letícia Paula Leonart Garmatter,Maria Aparecida do Carmo Rego,Angélica Nogueira-Rodrigues

DOI: https://doi.org/10.1371/journal.pone.0312757

IF: 3.7

2024-10-31

PLoS ONE

Abstract:The aim of the study is to evaluate the treatment patterns, time to start treatment, and healthcare resources utilization (HCRU) of cervical cancer (CC) patients within the Brazilian public health system (SUS). This is an observational retrospective study using SUS administrative database (DATASUS). Data from January-2014 to December-2020 was gathered from patients with the ICD-10 C53 codes. From 2014 to 2020, 206,861 women were included, among whom 90,073 (43.5%) had stage information. Of staged patients, 60.7% (54,719) had advanced disease (stages III and IV) and the most performed treatments were chemoradiotherapy (CRT) (41.6%), surgery + CRT (19.1%), radiotherapy (RT) only (16.8%) and chemotherapy (CT) only (13.3%). The proportion of patients submitted to CT in advanced stages was higher than in non-advanced stages (I and II), in contrast to RT, which was more frequent in stage I than stage IV. Median time to initiate treatment surpassed two months in approximately 30% of the cases, regardless of stage. Conization was the most performed surgical procedure. The hospitalization rate per patient per month for stage IV was twice as high as stage I (0.05 [95%CI 0.05–0.05] and 0.11 [0.11–0.11], respectively). The same trend was observed for outpatient visits (0.54 [95%CI 0.53–0.55] and 0.96 [0.93–0.98], respectively). This study demonstrated a high proportion of advanced CC at diagnosis in Brazil. The treatment pattern showed that chemoradiotherapy was the most frequent regimen overall and the use of chemotherapy and HCRU increased with staging. These results could provide information to improve public policies towards access to prevention, diagnosis, and treatment of CC in Brazil.

multidisciplinary sciences
Exploring cervical cancer mortality in Brazil: an ecological study on socioeconomic and healthcare factors

Agnaldo Lopes da Silva Filho,Guilherme Reis Romualdo,Matheus Eduardo Soares Pinhati,Gabriel Lage Neves,Juliana Almeida Oliveira,Renato Moretti-Marques,Angélica Nogueira-Rodrigues,Audrey Tieko Tsunoda,Eduardo Batista Cândido

DOI: https://doi.org/10.1136/ijgc-2024-005738

2024-10-04

Abstract:Objective: To evaluate the correlation between socioeconomic and healthcare factors and cervical cancer mortality rates, as well as the accessibility to prevention and treatment across Brazilian states and macroregions. The aim is to highlight the multifaceted challenge of addressing cervical cancer mortality, particularly in low- and middle-income countries. Methods: This cross-sectional study analyzed public data from the Brazilian National Institute of Cancer (INCA), the National Institute of Geography and Statistics (IBGE), and the Brazilian Ministry of Health. Data were collected on indicators such as the Human Development Index (HDI), physician density, average household income, human papillomavirus (HPV) vaccine coverage, Pap smear screening rates, radiotherapy machine density, and non-White population rates by state and macroregion across Brazil. Spearman's rank correlation test and simple linear regression analysis were employed. Results: Cervical cancer mortality rates are statistically lower in women with health insurance, positive self-perception of health, located in states with a higher HDI, per capita household income, density of physicians, and radiotherapy machines per 1000 inhabitants. In contrast, mortality rates proportionally increase according to poverty levels, as expected, and rates of non-White population. Considering public health, HDI scores significantly affected Pap smear test coverage, the number of radiotherapy machines, and HPV vaccine uptake. The North and the Southeast regions have, respectively, the lowest and the highest socioeconomic indicators, proportional to their mortality rates. No significant correlation was found between mortality rates and HPV vaccine or Pap smear coverage. Conclusions: Cervical cancer mortality in Brazil is significantly influenced by socioeconomic and healthcare disparities. This study provides a data-driven basis for public health strategies that address both medical and social determinants of health.
Refractive error and ocular alignment in school-aged children from low-income areas of São Paulo, Brazil

Arthur Gustavo Fernandes,Rodrigo Galvão Vianna,Debora Cristina Gabriel,Bruna Gil Ferreira,Eduardo Parente Barbosa,Solange Rios Salomão,Mauro Campos

DOI: https://doi.org/10.1186/s12886-024-03710-4

IF: 2.086

2024-10-17

BMC Ophthalmology

Abstract:Uncorrected refractive errors and amblyopia are reported as the two main causes of childhood visual impairment and blindness worldwide. Our purpose was to evaluate refractive status, ocular alignment and effective refractive error coverage (eREC) of school-aged children from low-income areas of Sao Paulo city, Brazil.

ophthalmology
Clinical treatment and prognostic observation for different pathological infiltrations in 537 patients with unilateral retinoblastoma.

Yizhuo Wang,Dongsheng Huang,Jitong Shi,Jianmin Ma,Junyang Zhao,Bin Li,Xiaolin Xu,Huimin Hu,Yan Zhou,Yongchang Sun

DOI: https://doi.org/10.3760/cma.j.issn.0366-6999.20140915

IF: 6.133

2014-01-01

Chinese Medical Journal

Abstract:Background The use of post-enucleation adjuvant therapy to decrease the extraocular relapse rate is frequently considered, but there is much controversy about the indications for adjuvant therapy. The aim of this retrospective study was to observe the treatment and prognosis for different degrees of invasion of eye tissue in retinoblastoma (RB) and identify the indications for post-enucleation adjuvant therapy. Methods We recruited 537 children who had been diagnosed with unilateral RB and had received enucleation from January 2006 to December 2012 in our hospital, and divided them into three groups according to their number of histopathologic risk factors: 0 factor, 1 factor, or >= 2 factors. Histopathologic high-risk factors included invasion of the optic nerve posterior to the ethmoid plate (including optic nerve stumps) and extensive invasions of the choroid, sclera, anterior chamber, iris, and ciliary body. Treatment was delivered accordingly, and the prognosis of different degrees of histopathologic invasion was observed. The subjects were followed up for 6 months to 7 years (average follow-up time: 35 months). Statistical analysis was analyzed using X-2 test. P<0.05 was considered significant. Results Of the 537 RB patients who received enucleation, 25 died (overall survival: 95.3%). Of the 369 (68.7%) with no histopathologic risk factors, 1 died of recurrence, with a mortality rate of 0.3%, whereas of the 168 (31.3%) with histopathologic risk factors, 26 had recurrences and 24 died (mortality rate: 14.3%; P=0.000). Of the 93 patients (17.3%), each of whom had a single risk factor, nine had recurrences, 16 died (8.6%). Of the 75 patients (14%) with two or more high-risk factors, 16 died (21.3%). These differences were statistically significant between the three (P=0.000). Conclusion Chemotherapy is recommended for patients with histopathologic risk factors, especially those with two or more histopathologic risk factors.
Eye-Preserving Therapies for Advanced Retinoblastoma

Chuandi Zhou,Xuyang Wen,Yi Ding,Jingwen Ding,Mei Jin,Zhenyin Liu,Sha Wang,Minglei Han,Hongfeng Yuan,Yishuang Xiao,Li Wu,Jiancang Wang,Yangjun Li,Jiawei Yu,Yuechun Wen,Juan Ye,Rong Liu,Zhijun Chen,Shangcai Xue,Wei Lu,Hongfei Liao,Jizhe Cui,Dan Zhu,Fang Lu,Song Tang,Yu Wu,Tseden Yangkyi,Guanghong Zhang,Miershalijiang Wubuli,Huiyu Guo,Xian Wang,Yanjin He,Xunlun Sheng,Qing Wang,Yingxiu Luo,Jiayan Fan,Jinlei Qi,Zhangsheng Yu,Jia Tan,Jianhong Liang,Xiantao Sun,Liwen Jin,Xinji Yang,Jing Zhang,Xunda Ji,Junyang Zhao,Renbing Jia,Xianqun Fan

DOI: https://doi.org/10.1016/j.ophtha.2021.09.002

IF: 14.277

2022-02-01

Ophthalmology

Abstract:PurposeMultiple eye-preserving treatments have been widely used in China for the last 15 years, however, controversy remains on using eye-preserving therapies for advanced retinoblastoma (The International Intraocular Retinoblastoma Classification: groups D and E). This study attempts to estimate the impact of eye-preserving therapies for the long-term prognosis of advanced retinoblastoma with regard to overall survival and ocular salvage.DesignA retrospective cohort study covering all 31 provinces (38 retinoblastoma treating centers) of Chinese mainland.ParticipantsA total of 1678 patients diagnosed with groups D or E retinoblastoma from January 2006 to May 2016.MethodsMedical charts review was performed. The patients were divided into primary enucleation and eye-preserving groups, and they were followed up for survival status. The impact of initial treatment on survival was evaluated by Cox analyses.Main Outcome MeasuresOverall survival and final eye-preservation rate.ResultsAfter a median follow-up period of 43.9 months, 196 (12%) patients died, and the 5-year overall survival was 86%. In total, the eyeball preservation rate was 48%. In this cohort, 1172 (70%) patients had unilateral retinoblastoma, whereas 506 (30%) were bilateral. For unilateral patients, 570 (49%) eyes had primary enucleation, and 602 (51%) patients had eye-preserving therapies initially. During the follow-up (median: 45.6 months), 59 (10%) patients from primary enucleation group and 56 (9.3%) patients from eye-preserving group died. Multivariate Cox analyses indicated no significant difference in overall survival between the two groups (HR=1.25; 95%CI:0.85-1.84; p=0.250). For bilateral patients, only 95 (19%) eyes had primary enucleation, and 411 (81%) patients had eye-preserving therapies initially. During the follow-up (median: 40.1 months), 12 (13%) patients from primary enucleation group and 69 (17%) patients from eye-preserving group died. For bilateral retinoblastoma with the worse eye of group E, patients had primary enucleation exhibited better overall survival (HR=2.35; 95%CI:1.10-5.01; p=0.027), however, this survival advantage was not evident until passing 22.6 months after initial diagnosis.ConclusionEye-preserving therapies have been widely used for advanced retinoblastoma in China. Bilateral patients with the worse eye of group E initially underwent eye-preserving therapies exhibited a worse overall survival. The choice of primary treatment for advanced retinoblastoma should be carefully weighed.

ophthalmology
Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines

Lata Singh,Girish Chinnaswamy,Rachna Meel,Venkatraman Radhakrishnan,Renu Madan,Suyash Kulkarni,Archana Sasi,Tanvir Kaur,R. S. Dhaliwal,Sameer Bakhshi

DOI: https://doi.org/10.1007/s12098-024-05085-2

2024-03-16

Abstract:Retinoblastoma (RB) is the most common intraocular tumor in childhood. It is mainly caused by mutations in both alleles of the RB1 tumor suppressor gene that is found on chromosome 13 and regulates the cell cycle. Approximately 8000 children are diagnosed with RB globally each year, with an estimated 1500 cases occurring in India. The survival rate of RB has improved to more than 90% in the developed world. Leukocoria and proptosis are the most common presenting features of RB in Asian Indian populations. Most cases of RB are diagnosed by fundus examination followed by ultrasound. The International Classification of Retinoblastoma is the most used scheme for the staging and classification of intraocular RB in India. Prenatal testing and preimplantation genetic testing for RB may be beneficial in high-risk families. Histopathologic risk factors such as massive choroidal invasion and post-laminar optic nerve help in predicting the occurrence of metastasis in children with RB, while presence of microscopic residual disease requires aggressive adjuvant treatment in eyes enucleated for group E RB. The review provides a consensus document on diagnosis and genetics of RB in India.

pediatrics
Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil

P.E.G. Costa,J.H.P. Garcia,G.R. Coelho,M.A.P. Barros,E.B. Hyppolito,K.B. Pereira,T.D dos S. Rocha,G.C.G Costa

DOI: https://doi.org/10.1016/j.transproceed.2024.01.024

IF: 1.014

2024-02-01

Transplantation Proceedings

Abstract:Hepatocellular carcinoma remains a significant worldwide malignancy and an important cause of cancer-related death. The incidence is increasing globally. In Latin America, there is no consistent data on the epidemiology of hepatocellular carcinoma. However, Brazil is considered a country with an intermediate incidence of this liver neoplasm. In the state of Ceará, situated in the northeast region of Brazil, there are no consistent clinical and epidemiologic data on the actual incidence and the treatment of hepatocellular carcinoma. The purpose of this article is to describe epidemiologic characteristics and treatment forms of patients with hepatocellular carcinoma who were treated in a Liver Transplant Center. A retrospective observational study was conducted using the database from the register of 299 patients with hepatocellular carcinoma between June 2004 and February 2022. Only patients born in Ceará were included. Therefore, most patients were eligible, based on the Milan Criteria, to undergo liver transplantation with a Model End Stage Liver Disease score of 12.48 ± 4.66 points, and the waiting list time was approximately 7 months with 8.7% hepatocellular carcinoma recurrence after liver transplant. A total of 38.5 % of cases were outside the Milan criteria at the time of cancer diagnosis, and transarterial chemoembolization was the main treatment choice. In conclusion, the diagnosis of hepatocellular carcinoma in Ceará mainly occurs in male patients with hepatitis C or alcoholism, with a mean age of 61.55 years and a previous diagnosis of liver disease. Liver transplantation was the best curative therapeutic form in patients with cirrhosis and hepatocellular carcinoma in Ceará, where a significant number of patients were diagnosed with intermediate and advanced-stage hepatocellular carcinoma, so public health policies are important for the screening and monitoring of liver disease.

immunology,surgery,transplantation

Video Classification as IR Task: Experiments and Observations

Retinoblastoma treatment in a Brazilian population. Presentation and long‐term results

Strategies to improve diagnosis and access to treatment of retinoblastoma in low‐ and middle‐income countries: A systematic review

Philippine retinoblastoma initiative multi-eye center study 2010-2020

Role of apparent diffusion map in the evaluation of retinoblastoma

EPID-07. EPIDEMIOLOGICAL CHARACTERISTICS AND SURVIVAL OF PATIENTS WITH DIFFUSE GLIOMA IN BRAZIL: PRELIMINARY RESULTS OF A MULTICENTRIC RETROSPECTIVE STUDY - LACOG 0619

Improved SOVA-based decoding algorithm for tailbiting codes on wireless channels

Clinical Characteristics and Treatment Outcome of Children with Intraocular Retinoblastoma: A Report from A Chinese Cooperative Group

A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt

Myocardial contrast and transesophageal echocardiographic study of the left coronary artery from the main pulmonary artery.

Treatment outcomes in retinoblastoma and the effect of tumor topography

Urinary interleukin-8/creatinine level as a predictor of response to intravesical bacillus Calmette-Guerin therapy in bladder tumor patients.

Characteristics and prognosis of young breast cancer patients treated in a public comprehensive cancer centre in Brazil: A retrospective cohort study

Ruptured 'Baker's-type cyst' of the arm--a case study.

Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system

Exploring cervical cancer mortality in Brazil: an ecological study on socioeconomic and healthcare factors

Refractive error and ocular alignment in school-aged children from low-income areas of São Paulo, Brazil

Clinical treatment and prognostic observation for different pathological infiltrations in 537 patients with unilateral retinoblastoma.

Eye-Preserving Therapies for Advanced Retinoblastoma

Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines

Hepatocellular Carcinoma in Ceará: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil